Foghorn Therapeutics (FHTX) News Today

Foghorn Therapeutics logo
$1.83 +0.04 (+2.23%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$1.83 0.00 (0.00%)
As of 07:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Foghorn Therapeutics Latest News

HC Wainwright Analysts Increase Earnings Estimates for FHTX
Foghorn Therapeutics Shares Fall After Wedbush Downgrade
Foghorn extends losses as TD Cowen cuts on Lilly exit
BTIG Downgrades Foghorn Therapeutics to Neutral From Buy
Foghorn plunges as Lilly exits collaboration

Foghorn Therapeutics Media Mentions By Week

Foghorn Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FHTX
News Sentiment
▼
0.37

0.56
▲
Average
Healthcare
News Sentiment

Foghorn Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FHTX Articles
This Week
▼
16

3
▲
FHTX Articles
Average Week

Foghorn Therapeutics Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
Page Views
569
-32%
Get Foghorn Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FHTX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Foghorn Therapeutics dated 11/16/2026.
From Our Partners